Skip to main content
Erschienen in: Supportive Care in Cancer 4/2014

01.04.2014 | Original Article

Characteristics associated with the use of complementary health approaches among long-term cancer survivors

verfasst von: Stephanie J. Sohl, Kathryn E. Weaver, Gurjeet Birdee, Erin E. Kent, Suzanne C. Danhauer, Ann S. Hamilton

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to identify the prevalence and characteristics of long-term adult cancer survivors who use complementary health approaches (CHA).

Methods

Participants completed the Follow-up Care Use Among Survivors (FOCUS) Survey, a cross-sectional investigation of long-term cancer survivors. The use of CHA and reasons for use were assessed. A multivariable logistic regression model was applied to identify if predisposing, enabling, and need characteristics described in the Complementary and Alternative Medicine Healthcare Model were associated with CHA use in the past year.

Results

Long-term cancer survivors in the study (N = 1,666) were predominately female (62 %) and older (mean age = 69.5), with breast, prostate, colorectal, ovarian, and endometrial cancers. Thirty-three percent of survivors used CHA in the past year. Common reasons for CHA use were to relieve stress (28 %), treat or prevent cancer (21 %), relieve cancer-related symptoms (18 %), and deal with another condition (18 %). Predisposing (i.e., higher optimism) and need factors (i.e., experienced cancer-related symptoms, ever had depression/anxiety) were significantly associated with CHA (p-values < .05). Enabling factors (i.e., insurance coverage, financial resources) were not.

Conclusions

Cancer survivors continue to report a high prevalence of recent CHA use more than 5 years after initial diagnosis. Healthcare providers should be aware of increased use of CHA among subgroups of long-term cancer survivors in order to guide safe and optimal use.
Literatur
2.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef
6.
Zurück zum Zitat Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and meta-analysis. Integr Cancer Ther 11:187–203. doi:10.1177/1534735411423920 PubMedCrossRef Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and meta-analysis. Integr Cancer Ther 11:187–203. doi:10.​1177/​1534735411423920​ PubMedCrossRef
8.
Zurück zum Zitat Fong HHS (2002) Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 1:287–293PubMedCrossRef Fong HHS (2002) Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 1:287–293PubMedCrossRef
9.
10.
Zurück zum Zitat Chen J-L, Wang J-Y, Tsai Y-F, Lin YH, Tseng LM, Chang WC, King KL, Chen WS, Chiu JH, Shyr YM (2013) In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab. Menopause 20:646–654PubMed Chen J-L, Wang J-Y, Tsai Y-F, Lin YH, Tseng LM, Chang WC, King KL, Chen WS, Chiu JH, Shyr YM (2013) In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab. Menopause 20:646–654PubMed
11.
Zurück zum Zitat Chandwani KD, Ryan JL, Peppone LJ, Janelsins MM, Sprod LK, Devine K, Trevino L, Gewandter J, Morrow GR, Mustian KM (2012) Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med. doi:10.1155/2012/979213 PubMedCentralPubMed Chandwani KD, Ryan JL, Peppone LJ, Janelsins MM, Sprod LK, Devine K, Trevino L, Gewandter J, Morrow GR, Mustian KM (2012) Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med. doi:10.​1155/​2012/​979213 PubMedCentralPubMed
12.
Zurück zum Zitat Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef
13.
Zurück zum Zitat Habermann TM, Thompson CA, LaPlant BR, Bauer BA, Janney CA, Clark MM, Rummans TA, Maurer MJ, Sloan JA, Geyer SM, Cerhan JR (2009) Complementary and alternative medicine use among long‐term lymphoma survivors: a pilot study. Am J Hematol 84:795–798. doi:10.1002/ajh.21554 PubMedCentralPubMedCrossRef Habermann TM, Thompson CA, LaPlant BR, Bauer BA, Janney CA, Clark MM, Rummans TA, Maurer MJ, Sloan JA, Geyer SM, Cerhan JR (2009) Complementary and alternative medicine use among long‐term lymphoma survivors: a pilot study. Am J Hematol 84:795–798. doi:10.​1002/​ajh.​21554 PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat American Cancer Society (2012) Cancer treatment and survivorship facts and figures 2012-2013. American Cancer Society, Atlanta American Cancer Society (2012) Cancer treatment and survivorship facts and figures 2012-2013. American Cancer Society, Atlanta
16.
Zurück zum Zitat Fouladbakhsh JM, Stommel M. (2007) Using the behavioral model for complementary and alternative medicine: the CAM Healthcare Model. J Complement Integr Med. 4:Article 11. doi: 10.2202/1553-3840.1035 Fouladbakhsh JM, Stommel M. (2007) Using the behavioral model for complementary and alternative medicine: the CAM Healthcare Model. J Complement Integr Med. 4:Article 11. doi: 10.​2202/​1553-3840.​1035
17.
Zurück zum Zitat Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 51:95–124PubMedCrossRef Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 51:95–124PubMedCrossRef
18.
Zurück zum Zitat Hamilton AS, Miller MF, Arora NK, Bellizzi KM, Rowland JH (2013) Predictors of use of complementary and alternative medicine by non-hodgkin lymphoma survivors and relationship to quality of life. Integr Cancer Ther 12:225–235. doi:10.1177/1534735412449733 PubMedCrossRef Hamilton AS, Miller MF, Arora NK, Bellizzi KM, Rowland JH (2013) Predictors of use of complementary and alternative medicine by non-hodgkin lymphoma survivors and relationship to quality of life. Integr Cancer Ther 12:225–235. doi:10.​1177/​1534735412449733​ PubMedCrossRef
19.
Zurück zum Zitat Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11:42–49PubMed Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11:42–49PubMed
20.
Zurück zum Zitat Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC (1999) Complementary therapy use among older cancer patients. Cancer Pract 7:136–144PubMedCrossRef Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC (1999) Complementary therapy use among older cancer patients. Cancer Pract 7:136–144PubMedCrossRef
21.
Zurück zum Zitat Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 100:219–227. doi:10.1007/s10549-006-9239-3 PubMedCrossRef Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 100:219–227. doi:10.​1007/​s10549-006-9239-3 PubMedCrossRef
22.
Zurück zum Zitat Davidson R, Geoghegan L, McLaughlin L, Woodward R (2005) Psychological characteristics of cancer patients who use complementary therapies. Psychooncology 14:187–195. doi:10.1002/pon.834 PubMedCrossRef Davidson R, Geoghegan L, McLaughlin L, Woodward R (2005) Psychological characteristics of cancer patients who use complementary therapies. Psychooncology 14:187–195. doi:10.​1002/​pon.​834 PubMedCrossRef
26.
Zurück zum Zitat Fouladbakhsh J, Stommel M (2010) Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol Nurs Forum 37:E7–E15PubMedCrossRef Fouladbakhsh J, Stommel M (2010) Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol Nurs Forum 37:E7–E15PubMedCrossRef
28.
Zurück zum Zitat Lövgren M, Wilde-Larsson B, Hök J, Leveälahti H, Tishelman C (2011) Push or pull? Relationships between lung cancer patients’ perceptions of quality of care and use of complementary and alternative medicine. Eur J Oncol Nurs 15:311–317. doi:10.1016/j.ejon.2010.10.004 PubMedCrossRef Lövgren M, Wilde-Larsson B, Hök J, Leveälahti H, Tishelman C (2011) Push or pull? Relationships between lung cancer patients’ perceptions of quality of care and use of complementary and alternative medicine. Eur J Oncol Nurs 15:311–317. doi:10.​1016/​j.​ejon.​2010.​10.​004 PubMedCrossRef
29.
Zurück zum Zitat Saini A, Berruti A, Capogna S, Negro M, Sguazzotti E, Picci RL, Campagna S, Dongiovanni V, Dogliotti L, Furlan PM, Ostacoli L (2011) Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. Qual Life Res 20:683–690. doi:10.1007/s11136-010-9795-1 PubMedCrossRef Saini A, Berruti A, Capogna S, Negro M, Sguazzotti E, Picci RL, Campagna S, Dongiovanni V, Dogliotti L, Furlan PM, Ostacoli L (2011) Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. Qual Life Res 20:683–690. doi:10.​1007/​s11136-010-9795-1 PubMedCrossRef
30.
Zurück zum Zitat Lo-Fo-Wong DNN, Ranchor AV, De Haes HCJM, Sprangers MAG, Henselmans I (2012) Complementary and alternative medicine use of women with breast cancer: self-help CAM attracts other women than guided CAM therapies. Patient Educ Couns 89:529–536. doi:10.1016/j.pec.2012.02.019 PubMedCrossRef Lo-Fo-Wong DNN, Ranchor AV, De Haes HCJM, Sprangers MAG, Henselmans I (2012) Complementary and alternative medicine use of women with breast cancer: self-help CAM attracts other women than guided CAM therapies. Patient Educ Couns 89:529–536. doi:10.​1016/​j.​pec.​2012.​02.​019 PubMedCrossRef
31.
Zurück zum Zitat Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, Oakley-Girvan I, Beckjord EB, Aziz NM (2012) Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns 89:345–352. doi:10.1016/j.pec.2012.08.014 PubMedCrossRef Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, Oakley-Girvan I, Beckjord EB, Aziz NM (2012) Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns 89:345–352. doi:10.​1016/​j.​pec.​2012.​08.​014 PubMedCrossRef
32.
Zurück zum Zitat Bellizzi KM, Aziz NM, Rowland JH, Weaver K, Arora NK, Hamilton AS, Oakley-Girvan I, Keel G (2012) Double jeopardy? Age, race, and HRQOL in older adults with cancer. J Cancer Epidemiol. doi:10.1155/2012/478642, Epub 2012 Jul 25PubMedCentralPubMed Bellizzi KM, Aziz NM, Rowland JH, Weaver K, Arora NK, Hamilton AS, Oakley-Girvan I, Keel G (2012) Double jeopardy? Age, race, and HRQOL in older adults with cancer. J Cancer Epidemiol. doi:10.​1155/​2012/​478642, Epub 2012 Jul 25PubMedCentralPubMed
33.
Zurück zum Zitat Hamilton A, Cockburn M, Chen X, Deapen D (2005) Factors associated with the use of complementary and alternative medicine by cancer patients in Los Angeles County. J Cancer Integr Med 3:51–61. doi:10.1177/1534735412449733 CrossRef Hamilton A, Cockburn M, Chen X, Deapen D (2005) Factors associated with the use of complementary and alternative medicine by cancer patients in Los Angeles County. J Cancer Integr Med 3:51–61. doi:10.​1177/​1534735412449733​ CrossRef
34.
37.
Zurück zum Zitat Stiggelbout AM, De Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K, Kievit J (1997) Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 75:914–920PubMedCentralPubMedCrossRef Stiggelbout AM, De Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K, Kievit J (1997) Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 75:914–920PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Arora N, Hamilton A, Potosky A, Rowland JH, Aziz NM, Bellizzi KM, Klabunde CN, McLaughlin W, Stevens J (2007) Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv 1:49–63. doi:10.1007/s11764-007-0004-3 PubMedCrossRef Arora N, Hamilton A, Potosky A, Rowland JH, Aziz NM, Bellizzi KM, Klabunde CN, McLaughlin W, Stevens J (2007) Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv 1:49–63. doi:10.​1007/​s11764-007-0004-3 PubMedCrossRef
39.
Zurück zum Zitat Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233PubMedCrossRef Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233PubMedCrossRef
41.
43.
Zurück zum Zitat Birdee GS, Legedza AT, Saper RB, Bertisch SM, Eisenberg DM, Phillips RS (2008) Characteristics of yoga users: results of a national survey. J Gen Intern Med 23:1653–1658PubMedCentralPubMedCrossRef Birdee GS, Legedza AT, Saper RB, Bertisch SM, Eisenberg DM, Phillips RS (2008) Characteristics of yoga users: results of a national survey. J Gen Intern Med 23:1653–1658PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 10:1–23 Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 10:1–23
45.
Zurück zum Zitat Watt L, Gulati S, Shaw NT, Sung L, Dix D, Poureslami I, Klassen AF (2012) Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer. Support Care Cancer 20:253–260. doi:10.1007/s00520-010-1063-y PubMedCrossRef Watt L, Gulati S, Shaw NT, Sung L, Dix D, Poureslami I, Klassen AF (2012) Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer. Support Care Cancer 20:253–260. doi:10.​1007/​s00520-010-1063-y PubMedCrossRef
Metadaten
Titel
Characteristics associated with the use of complementary health approaches among long-term cancer survivors
verfasst von
Stephanie J. Sohl
Kathryn E. Weaver
Gurjeet Birdee
Erin E. Kent
Suzanne C. Danhauer
Ann S. Hamilton
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-2040-z

Weitere Artikel der Ausgabe 4/2014

Supportive Care in Cancer 4/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.